Biogen appoints new exec VP

Amy Schofield 01 April 2016

Biogen has appointed Michel Vounatsos as its executive vice-president and chief commercial officer.

Mr Vounatsos most recently served as president of Merck Sharp and Dohme's primary care and customer centricity units, as part of a 20-year career with the company.

He will be responsible for overseeing the development and execution of Biogen's global commercial strategy, with a focus on the continued growth of its product portfolio and the development of its commercial infrastructure.

Dr George Scangos, chief executive officer of Biogen, said: "Michel will play a critical role in driving our near-term growth while helping prepare our organisation to support our increasingly robust and diverse pipeline."

Mr Vounatsos will take up his new post on April 18th.


Make a comment

To voice your opinion, please Log in or Register.

Pf Magazine

Your resource for news, features, interviews, careers and events in the pharma industry.

Click here for the latest issue and to subscribe.